Evidence map›Paper›PMID 30778113›Full record

ArticleScientific reports2019

Aurora A controls CD8

Eugenio Bustos-Morán, Noelia Blas-Rus, Ana Alcaraz-Serna, Salvador Iborra, José González-Martínez, Marcos Malumbres, Francisco Sánchez-Madrid

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Eugenio Bustos-MoránServicio de Inmunología, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.
Noelia Blas-RusServicio de Inmunología, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.
Ana Alcaraz-SernaServicio de Inmunología, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.
Salvador IborraDepartment of Immunology, Ophthalmology and ENT. Complutense University School of Medicine and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
José González-MartínezCell Division and Cancer group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
Marcos MalumbresCell Division and Cancer group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.ORCID 0000-0002-0829-6315
Francisco Sánchez-MadridServicio de Inmunología, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain. fsmadrid@salud.madrid.org.
Hospital Universitario de La Princesa · ESSpanish National Cancer Research Centre · ESResearch Institute Hospital 12 de Octubre · ESSpanish National Centre for Cardiovascular Research · ES

Funding

European Research Council 294340
6 · The paper itself

Abstract

Aurora A is a serine/threonine kinase whose role in cell cycle progression and tumour generation has been widely studied. Recent work has revealed an unexpected function for Aurora A during CD4

Indexed as

AnimalsAurora Kinase ACD8-Positive T-LymphocytesCytotoxicity, ImmunologicDisease Models, AnimalHost-Pathogen InteractionsHumansImmunomodulationLymphocyte ActivationMaleMiceMice, TransgenicReceptors, Antigen, T-CellSignal TransductionVacciniaVaccinia virusAURKA protein, humanAurora Kinase AReceptors, Antigen, T-Cell

Identifiers

PMID30778113
PMCPMC6379542
OpenAlexW2918081213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.